UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 8, 2022
Accession Number:
0001104659-22-124554
Submission Type:
POS AM
CIK:
0000894158
Company Name:
Theriva Biologics, Inc.
File Number:
333-267294